Impact Biomedical (IBO) Share-based Compensation (2024 - 2026)
Impact Biomedical (IBO) posted Share-based Compensation of $1.4 million for Q1 2026, up 17900.0% on a QoQ basis from $8000.0 in Q4 2025, and up 71900.0% year-over-year from N/an in Q1 2025.
Impact Biomedical (IBO) Share-based Compensation (2024 - 2026) Analysis & Trends
Impact Biomedical's Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Share-based Compensation rose 71900.0% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 6809.52% YoY) and the FY2025 annual result came in at $13000.0, down 31.58% from the prior year.
- Share-based Compensation was $1.4 million for Q1 2026 at Impact Biomedical, up from $8000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.4 million in Q1 2026 and bottomed at $1000.0 in Q3 2025.
- A 3-year average of $245333.3 and a median of $5000.0 in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2025 — Share-based Compensation slumped 57.89% — and 2026, when it jumped 71900.0%.
- Impact Biomedical's Share-based Compensation stood at $19000.0 in 2024, then slumped by 57.89% to $8000.0 in 2025, then jumped by 17900.0% to $1.4 million in 2026.
- Business Quant data shows IBO's Share-based Compensation at $1.4 million in Q1 2026, $8000.0 in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Dec 31, 2024 | 19,000.00 |